Items where authors include "Rajbhandari, S."

Article

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Tesfaye, S., Sloan, G., Petrie, J. et al. (29 more authors) (2022) Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. The Lancet, 400 (10353). pp. 680-690. ISSN 0140-6736

Santos, J.M.M., Rajbhandari, S., Tsonev, D. et al. (8 more authors) (2016) Visible light communication using InGaN optical sources with AlInGaP nanomembrane down-converters. Optics Express, 24 (9). pp. 10020-10029. ISSN 1094-4087

Proceedings Paper

Leitao, M., Santos, J., Foucher, C. et al. (12 more authors) (2016) Colloidal quantum dot and epitaxial quantum-well platelet colour-converters for visible light communication. In: Semiconductor and Integrated Optoelectronics SIOE'16. Semiconductor and Integrated Optoelectronics SIOE'16, 05-07 Apr 2016, Cardiff, Wales. .